7-hydroxymitragynine (7-OH) is kratom’s second-famous alkaloid — present in the natural leaf at barely detectable levels, yet the single most regulated compound in the category as of 2026. Understanding why requires two separate stories: what 7-OH is chemically, and what happened when the industry began concentrating it into products that no longer resemble the leaf at all.
The chemistry
7-OH is a natural oxidative derivative of mitragynine — the two are structurally close, but 7-OH is far more potent at the receptors that matter, and it is present in raw dried leaf only in trace amounts: typically hundredths of a percent of dry weight. Drying method moves the number — sun-curing and fermentation measurably raise 7-OH content, which is part of how vein colors are made. The parent alkaloid’s story is in what is mitragynine.
The concentrate boom
Through the early 2020s, manufacturers began isolating and concentrating 7-OH — and semi-synthesizing it from mitragynine — for a wave of ultra-potent tablets and shots marketed as “7-OH” products. These contained orders of magnitude more 7-OH than any natural leaf. Users reported steep tolerance curves and dependence-like patterns; regulators responded. The industry term for the divide: natural-trace 7-OH in plain leaf versus added or concentrated 7-OH — legally and pharmacologically different products sharing one ingredient’s name.
The 2025–2026 regulatory wave
- Florida — banned concentrated 7-OH as Schedule I in 2025, natural leaf unaffected. See the Florida guide.
- Ohio — made its ban on synthetic 7-OH concentrates permanent in 2026.
- Tennessee, Connecticut, Kansas and Louisiana — full kratom bans in which 7-OH products featured prominently in the legislative record: the ban-state list.
- Federal — the DEA scheduled synthetic kratom analogs in 2026, with 7-OH threshold rules under review; the full picture is in the FDA and kratom.
Where we stand
Our products are standardized to mitragynine and contain no added 7-hydroxymitragynine — whatever 7-OH is present is the natural trace of the source leaf, and every batch’s alkaloid panel is published on the lab tests page. That is a deliberate product decision: the regulatory and dependence profile of concentrated 7-OH products is exactly the risk we did not want in our range. The distinction is unpacked further in extracts vs plain leaf.
What a buyer should check
- Read the COA’s alkaloid panel — 7-OH far above trace levels means a concentrate. See how to read a COA.
- Confirm your state’s current law before ordering — kratom laws by state.
- Treat any product marketed purely around 7-OH potency as a high-risk category, legally and physiologically.
Related reading
- What is mitragynine? — the parent alkaloid.
- Kratom alkaloids 101 — the complete profile.
- Is kratom addictive? — dependence, honestly explained.
These statements have not been evaluated by the FDA. Kratom is not intended to diagnose, treat, cure or prevent any disease. Adults 21+ only. Regulatory information current as of late 2026; verify current law for your jurisdiction.
Ready to order lab-tested kratom?
Every Pure Ohms batch ships with an independent Certificate of Analysis, is manufactured in a GMP-certified facility, and dispatches the same day from the USA. A $120 merchandise minimum applies. Standard shipping is $25 to eligible USA and Canada addresses, and free on merchandise subtotals over $500.